Suppr超能文献

印度的流感疫苗接种:印度儿科学会 2013 年立场文件。

Influenza vaccination in India: position paper of Indian Academy of Pediatrics, 2013.

机构信息

Advisory Committee on Vaccines and Immunization Practices, Indian Academy of Pediatrics. Correspondence to: Dr Vipin M Vashishtha, Convener, IAP Advisory Committee on Vaccines and Immunization Practices (ACVIP), Mangla Hospital and Research Center, Shakti Chowk, Bijnor, Uttar Pradesh, 246701, India.

出版信息

Indian Pediatr. 2013 Sep;50(9):867-74. doi: 10.1007/s13312-013-0230-x.

Abstract

Burden of Influenza is significantly higher in developing countries as compared to developed countries, but the data on the disease burden is less well defined in most of the developing countries including India, and consequently, constraints evolving strategies for prioritization of measures to prevent and control it. The swine flu or A(H1N1) pandemic is on the wane but the virus continues to circulate causing sporadic outbreaks even in 2013. The A(H1N1)pdm09 has replaced the previous circulating seasonal A (H1N1) virus and acquired the status of a seasonal virus. Limited influenza activity is usually seen throughout the year in India with a clear peaking during the rainy season. The rainy season in the country lasts from June to August in all the regions except Tamil Nadu where it occurs from October to December. IAP recommends the ideal time for offering influenza vaccines is just before the onset of rainy season. The efficacy/effectiveness data of trivalent inactivated influenza vaccines are also presented in different age groups and different categories of individuals. The IAP maintains its earlier recommendations of using the current trivalent inactivated influenza vaccine in all children with risk factors but not as a universal measure. IAP has now prioritized different target groups for influenza vaccination based on contribution of the group to the overall influenza burden, disease severity, and vaccine effectiveness in different age groups and categories. The current trivalent inactivated influenza vaccines incorporate the 2009 pandemic strain also, hence avert the need of a separate A (H1N1) vaccine. IAP stresses the need of more refined surveillance; large scale studies on effectiveness of seasonal influenza vaccines in Indian children, and more effective, properly matched, higher-valent influenza vaccines.

摘要

发展中国家的流感负担明显高于发达国家,但包括印度在内的大多数发展中国家对疾病负担的数据定义较少,因此,为预防和控制流感而制定的优先措施的策略受到限制。猪流感或 A(H1N1)大流行正在减弱,但该病毒仍在继续传播,导致即使在 2013 年也会出现零星爆发。A(H1N1)pdm09 已经取代了以前流行的季节性 A(H1N1)病毒,并获得了季节性病毒的地位。印度全年的流感活动通常较少,但在雨季期间会明显达到高峰。该国除泰米尔纳德邦外,所有地区的雨季都从 6 月持续到 8 月,在泰米尔纳德邦,雨季从 10 月持续到 12 月。IAP 建议提供流感疫苗的理想时间是在雨季开始前。还介绍了不同年龄组和不同类别的人群中三价灭活流感疫苗的疗效/效果数据。IAP 维持了其早期的建议,即在所有有危险因素的儿童中使用当前的三价灭活流感疫苗,但不作为普遍措施。IAP 现在根据群体对总体流感负担、疾病严重程度以及不同年龄组和类别的疫苗效果的贡献,为流感疫苗接种确定了不同的目标群体。目前的三价灭活流感疫苗还包含了 2009 年的大流行株,因此无需单独的 A(H1N1)疫苗。IAP 强调需要更精细的监测;在印度儿童中进行季节性流感疫苗效果的大规模研究,以及更有效、适当匹配、更高价的流感疫苗。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验